Viswa Colluru
Viswa is CEO of Enveda Biosciences. He founded Enveda after leading cross-functional teams across innovation, product strategy, and translational biology as an early employee at Recursion Pharmaceuticals. He holds a Ph.D. in immuno-oncology from the University of Wisconsin-Madison, where he developed new therapeutic agents for the treatment of prostate cancer. At Enveda, he leads a world-class team of machine learning scientists and drug hunters engaged in unlocking the potential of nature’s chemistry for drug discovery. By leveraging breakthroughs in computational metabolomics and machine learning, the Enveda platform works like a “chemical search engine” to predict new drug-like chemicals at scale. Enveda’s internal teams then advance these drug candidates through preclinical and clinical testing. With an initial focus on unraveling the chemical secrets of medicinal plants that have been used for thousands of years, Enveda’s first molecules are targeted tow
MedCity News
Arch Oncology adds $105M for better way to get immune cells to gobble up tumors
Several companies are developing immunotherapies targeting the “don’t eat me” cancer protein CD47. Arch Oncology, which is developing drugs with features that could set them apart from this field, now has $105 million for multiple clinical trials.
Shares0
The first wave of cancer drugs that clear the way for a certain immune cell to gobble up tumors has yet to reach the market, but Arch Oncology is already developing what it calls the “next-generation” of this type of cancer immunotherapy and it has raised $105 million in fresh capital to advance multiple clinical tests of its lead asset.
MedCity News
Wireless carriers wade into telehealth
Mobile carriers like Verizon and T-Mobile are dipping their toe into telehealth through partnerships and acquisitions. Earlier this month, Verizon rolled out a telehealth platform based on video conferencing software BlueJeans
Shares0
Verizon rolled out a telehealth service after acquiring video conferencing platform BlueJeans last year. Photo credit: Verizon
A handful of wireless carriers are testing out new telehealth efforts. In the last month, Verizon and T-Mobile have dipped their toes into telehealth through partnerships and acquisitions.
Verizon embedded it into Epic’s electronic health record system, and also implemented a virtual “waiting room” with a pre-visit survey and educational materials. It also plans to offer medical interpretation, captioning and transcription services.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
John Matthews
John Matthews is the Managing Director of Healthcare and Life Sciences at Teradata. As a consultant to some of the largest, most innovative, and most complex US and global healthcare companies, Matthews designs data analytics solutions that allow these organizations to thrive in a fast changing industry. With a background in business intelligence and data warehousing, he has helped numerous businesses adapt to big data analytics, primarily in health care and international development. Matthews is a graduate of the University of Virginia and resides in Charlottesville, Virginia.